Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Pharmacodynamics and Pharmacokinetics of Citalopram and Escitalopram (PGRN-SSRI)

This study has been completed.
Sponsor:
Collaborators:
Information provided by (Responsible Party):
Daniel K. Hall-Flavin, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT00613470
First received: January 30, 2008
Last updated: December 16, 2013
Last verified: December 2013